BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 31091203)

  • 1. Small and Isolated Immunohistochemistry-positive Cells in Melanoma Sentinel Lymph Nodes Are Associated With Disease-specific and Recurrence-free Survival Comparable to that of Sentinel Lymph Nodes Negative for Melanoma.
    LeBlanc RE; Barton DT; Li Z; Angeles CV; Ernstoff MS; Bagley E; Wimmer D; Wong SL; Barth RJ; Shirai K; Yan S
    Am J Surg Pathol; 2019 Jun; 43(6):755-765. PubMed ID: 31091203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of micrometastatic disease in melanoma sentinel lymph nodes by enhanced pathology: recommendations for standardizing pathologic analysis.
    Spanknebel K; Coit DG; Bieligk SC; Gonen M; Rosai J; Klimstra DS
    Am J Surg Pathol; 2005 Mar; 29(3):305-17. PubMed ID: 15725798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sentinel Lymph Nodes in Classic Invasive Lobular Carcinoma of the Breast: Cytokeratin Immunostain Ensures Detection, and Precise Determination of Extent, of Involvement.
    Patel A; D'Alfonso T; Cheng E; Hoda SA
    Am J Surg Pathol; 2017 Nov; 41(11):1499-1505. PubMed ID: 28877063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of BRAF V600E mutational status in capsular nevi of sentinel lymph nodes in patients with primary cutaneous melanoma.
    Siroy AE; Aung PP; Torres-Cabala CA; Tetzlaff MT; Nagarajan P; Milton DR; Curry JL; Ivan D; Prieto VG
    Hum Pathol; 2017 Jan; 59():48-54. PubMed ID: 27666765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Worse outcome for patients with recurrent melanoma after negative sentinel lymph biopsy as compared to sentinel-positive patients.
    Gambichler T; Scholl L; Bechara FG; Stockfleth E; Stücker M
    Eur J Surg Oncol; 2016 Sep; 42(9):1420-6. PubMed ID: 27160354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Significance of "Nonsolid" Microscopic Metastasis in Merkel Cell Carcinoma Sentinel Lymph Nodes.
    Erstine EM; Tetzlaff MT; Jia X; Aung PP; Prieto VG; Funchain P; Gastman BR; Billings SD; Ko JS
    Am J Surg Pathol; 2019 Jul; 43(7):907-919. PubMed ID: 31094923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the non-sentinel lymph node compartment the next site for melanoma progression from the sentinel lymph node compartment in the regional nodal basin?
    Rios-Cantu A; Lu Y; Melendez-Elizondo V; Chen M; Gutierrez-Range A; Fadaki N; Thummala S; West-Coffee C; Cleaver J; Kashani-Sabet M; Leong SPL
    Clin Exp Metastasis; 2017 Jun; 34(5):345-350. PubMed ID: 28699042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete lymph node dissection or observation in melanoma patients with multiple positive sentinel lymph nodes: A single-center retrospective analysis.
    Persa OD; Knuever J; Mauch C; Schlaak M
    J Dermatol; 2018 Oct; 45(10):1191-1194. PubMed ID: 30095864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sentinel lymph nodes containing very small (<0.1 mm) deposits of metastatic melanoma cannot be safely regarded as tumor-negative.
    Murali R; DeSilva C; McCarthy SW; Thompson JF; Scolyer RA
    Ann Surg Oncol; 2012 Apr; 19(4):1089-99. PubMed ID: 22271204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frozen section analysis of SLNs in trunk and extremity melanoma has a high false negative rate but can spare some patients a second operation.
    Fahy AS; Grotz TE; Keeney GL; Glasgow AE; Habermann EB; Erickson L; Hieken TJ; Jakub JW
    J Surg Oncol; 2016 Dec; 114(7):879-883. PubMed ID: 27634587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Greater Tumor Thickness, Ulceration, and Positive Sentinel Lymph Node Are Associated With Worse Prognosis in Patients With Conjunctival Melanoma: Implications for Future AJCC Classifications.
    Esmaeli B; Rubin ML; Xu S; Goepfert RP; Curry JL; Prieto VG; Ning J; Tetzlaff MT
    Am J Surg Pathol; 2019 Dec; 43(12):1701-1710. PubMed ID: 31425167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
    Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
    Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative measurement of melanoma spread in sentinel lymph nodes and survival.
    Ulmer A; Dietz K; Hodak I; Polzer B; Scheitler S; Yildiz M; Czyz Z; Lehnert P; Fehm T; Hafner C; Schanz S; Röcken M; Garbe C; Breuninger H; Fierlbeck G; Klein CA
    PLoS Med; 2014 Feb; 11(2):e1001604. PubMed ID: 24558354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. False-positive cells in sentinel lymph nodes.
    Brennick JB; Yan S
    Semin Diagn Pathol; 2008 May; 25(2):116-9. PubMed ID: 18697715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of recurrence after sentinel lymph node biopsy for cutaneous melanoma.
    Fincher TR; McCarty TM; Fisher TL; Preskitt JT; Lieberman ZH; Stephens JF; O'Brien JC; Kuhn JA
    Am J Surg; 2003 Dec; 186(6):675-81. PubMed ID: 14672778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Staging of Sentinel Lymph Nodes Identifies Melanoma Patients at Increased Risk of Nodal Recurrence.
    Kimbrough CW; Egger ME; McMasters KM; Stromberg AJ; Martin RC; Philips P; Scoggins CR
    J Am Coll Surg; 2016 Apr; 222(4):357-63. PubMed ID: 26875070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphatic invasion predicts sentinel lymph node metastasis and adverse outcome in primary cutaneous melanoma.
    Moy AP; Mochel MC; Muzikansky A; Duncan LM; Kraft S
    J Cutan Pathol; 2017 Sep; 44(9):734-739. PubMed ID: 28555886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency and implications of occipital and posterior auricular sentinel lymph nodes in scalp melanoma.
    Carmichael H; King BBT; Friedman C; Torphy RJ; Medina T; Gleisner A; McCarter MD; Kwak JJ; Kounalakis N
    J Surg Oncol; 2019 Dec; 120(8):1470-1475. PubMed ID: 31614003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surveillance of Sentinel Node-Positive Melanoma Patients with Reasons for Exclusion from MSLT-II: Multi-Institutional Propensity Score Matched Analysis.
    Broman KK; Hughes TM; Dossett LA; Sun J; Carr MJ; Kirichenko DA; Sharma A; Bartlett EK; Nijhuis AA; Thompson JF; Hieken TJ; Kottschade L; Downs J; Gyorki DE; Stahlie E; van Akkooi A; Ollila DW; Frank J; Song Y; Karakousis G; Moncrieff M; Nobes J; Vetto J; Han D; Farma J; Deneve JL; Fleming MD; Perez M; Baecher K; Lowe M; Bagge RO; Mattsson J; Lee AY; Berman RS; Chai H; Kroon HM; Teras RM; Teras J; Farrow NE; Beasley GM; Hui JY; Been L; Kruijff S; Boulware D; Sarnaik AA; Sondak VK; Zager JS;
    J Am Coll Surg; 2021 Apr; 232(4):424-431. PubMed ID: 33316427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sentinel lymph node micrometastasis as a predictor of axillary tumor burden.
    Dabbs DJ; Fung M; Landsittel D; McManus K; Johnson R
    Breast J; 2004; 10(2):101-5. PubMed ID: 15009035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.